Large South Korean Contract Research Organization Selects Oracle Health Sciences InForm to Speed Clinical Trials
LSK Global PS Optimizes Clinical Development Processes With Oracle Health Sciences Cloud Solution
Opinionmeter–s Mobile Electronic Data Capture Solution Automates Field Audit and Compliance Requirements of Energy Exploration Companies
Large Oil and Gas Producers Are Now Using Opinionmeter–s Data Capture Software to Automate and Digitize Compliance, Safety and Risk Assessment Forms
OmniComm Systems Announces Innovative New Release of TrialMaster(R) EDC
EDC Platform Offering Direct Data Entry by Patients, Foreign Language Support, and Automated E2B Safety Reporting
Veloxis Pharmaceuticals Chooses TrialMaster(R) EDC for Risk-Based Monitoring
FORT LAUDERDALE, FL — (Marketwired) — 03/11/15 — OmniComm Systems, Inc. (OmniComm) (OTCQB: OMCM), a global leading provider of clinical data management technology, today announced that after a rigorous evaluation process of various commercially available EDC technologies, Veloxis selected TrialMaster EDC to run its Phase IV clinical studies.TrialMaster–s risk-based monitoring capability was a significant factor in the selection decision. The ability to collect and utilize many types of key
OmniComm Systems(R) TrialOne(R) Suite Selected by ICON for Phase I Clinic Automation
FORT LAUDERDALE, FL — (Marketwired) — 03/03/15 — OmniComm Systems, Inc. (OmniComm) (OTCQB: OMCM), a global leading provider of clinical data management technology, today announced the signing of a multi-year agreement with ICON for OmniComm Systems– market leading TrialOne technology for Phase I clinic automation. ICON is one of the world–s largest contract research organizations (CROs) with around 10,600 employees in 38 countries. ICON provides drug development solutions and services on a
European Group for Research in Schizophrenia Selects OmniComm Systems(R) TrialMaster(R) Risk-Based & Centralized Monitoring With Auto-Redaction to Reduce Monitoring Costs
FORT LAUDERDALE, FL — (Marketwired) — 02/24/15 — OmniComm Systems, Inc. (OmniComm) (OTCQB: OMCM), a global leading provider of clinical data management technology, announces that the European Group for Research in Schizophrenia (EGRIS) has selected TrialMaster electronic data capture (EDC) technology with risk-based and centralized monitoring for its European Long-acting Antipsychotics in Schizophrenia Trial (EULAST). The EULAST trial will span 16 countries, involve 45 investigator sites, en
OmniComm Systems Appoints General Manager of China; Mr. Feng Cheng Focuses on Expanding Growth and Business Operations
FORT LAUDERDALE, FL — (Marketwired) — 02/09/15 — OmniComm Systems, Inc. (OmniComm) (OTCQB: OMCM), a global leading provider of clinical data management technology, announces the appointment of Mr. Feng Cheng as general manager of OmniComm, China. Mr. Cheng will lead OmniComm–s long-term regional strategy, identifying and developing business expansion and growth initiatives.Recent market research has estimated that the Asia-Pacific region is poised to grow at CAGR of 19.5% in the next five y
OmniComm Systems(R) Acquires IRT Technology From ClinQuest
TrialMaster(R) EDC Suite and IRTMaster(TM) Integrated for Faster Study Start-Up and Site Optimization
OmniComm Systems(R) Announces 141% YOY Growth in Total Contract Value
World–s Largest CROs and Pharmaceutical Companies Comprise 33% of Total Contract Value
OmniComm Systems(R) Recognizes Excellence in Clinical Research and Development at Innovation Forum 2014
Industry Leaders Convene to Demonstrate the Transformative Effect of OmniComm Technology